Oritavancin for the treatment of complicated gram-positive infection in persons who inject drugs
Abstract Background Treatment of complicated infections in persons who inject drugs (PWID) and patients experiencing homelessness poses a unique challenge to clinicians. Long-acting lipoglycopeptide antibiotics, such as oritavancin, may facilitate extended courses of outpatient intravenous therapy w...
Main Authors: | Aileen Ahiskali, Heather Rhodes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | BMC Pharmacology and Toxicology |
Online Access: | http://link.springer.com/article/10.1186/s40360-020-00452-z |
Similar Items
-
Real-World Evidence for Oritavancin Use in Gram-Positive Infections
Published: (2020-07-01) -
Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience
by: Lauren E. Brownell, et al.
Published: (2020-06-01) -
Real-World Evidence Studies of Oritavancin Use in Gram-Positive Infections Augment Randomized Controlled Trials to Address Clinical and Economic Outcomes
by: Mark Redell
Published: (2020-06-01) -
Real-World Use of Oritavancin for the Treatment of Osteomyelitis
by: Patrick J. Scoble, et al.
Published: (2020-06-01) -
Review of oritavancin for the treatment of acute bacterial skin and skin structure infections
by: Ana Alejandra García Robles, et al.
Published: (2018-03-01)